CRMD vs CTMX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CRMD Captures Institutional Edge (3โ1 Pillars ยท 6โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CorMedix Inc. (CRMD) driven by superior Valuation, Growth & Margin, Options & Structure while CTMX counters with relative strength in Momentum & Technical. Fundamentally, CRMD trades at 49.0x Forward P/E with 41.0% operating margin (-47.7% YoY revenue) versus CTMX at 14.2x Forward P/E and -676.4% operating margin (-71.7% YoY). In options structure, CRMD sits in BREAKDOWN (25th %ile IV; Dealer Gamma Walls on Pro) against CTMX sits in BREAKDOWN (60th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CRMD Revenue | CTMX Revenue | CRMD Op. Margin | CTMX Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | $60M | -6250.4% | -130.9% | CTMX |
| FY2019 | $0M | $30M | -7416.3% | -525.9% | CTMX |
| FY2020 | $0M | $70M | -11378.4% | -117.7% | CTMX |
| FY2021 | $0M | $40M | -15417.5% | -311.0% | CTMX |
| FY2022 | $0M | $50M | -46819.9% | -190.6% | CTMX |
| FY2023 | N/A | $100M | N/A | -6.4% | CTMX |
| FY2024 | $40M | $140M | -51.4% | 18.1% | CTMX |
| FY2025 | $310M | $80M | 48.2% | -29.3% | CRMD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CRMD | CTMX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $384.7M | $436.0M | Larger Scale | CTMX |
| Trailing P/E Ratio Valuation | 2.4x | 14.2x | Lower Multiple | CRMD |
| Forward P/E Ratio Valuation | 49.0x | 14.2x | Lower Multiple | CTMX |
| Revenue Growth (YoY) Growth | -47.7% | -71.7% | Higher Growth | CRMD |
| Operating Margin (TTM) Profitability | 41.0% | -676.4% | Higher Margin | CRMD |
| Net Profit Margin Profitability | 15.5% | 0.0% | Higher Margin | CRMD |
| Return on Equity (ROE) Capital Efficiency | 15.3% | -43.5% | Higher ROE | CRMD |
| 52-Week Range Position Momentum | 3% ($5โ$13) | 1% ($2โ$8) | Stronger Trend | CRMD |
| Beta / 30D Volatility Risk Regime | 1.20ฮฒ ยท 107% Vol | 1.48ฮฒ ยท 78% Vol | Lower Realized Risk | CTMX |
| Unified Institutional Score Composite Signal | 53.2 / 100 (HOLD) | 53.1 / 100 (HOLD) | Higher Composite | Tie |